Autolus Therapeutics plc (AUTL) PT Raised to $11 at Needham Dec 29, 2025 07:18AM
Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference Apr 2, 2025 07:00AM
Autolus Therapeutics (AUTL) Prices 58.33M Share Offering at $6/sh Feb 8, 2024 07:01AM
Autolus Announces Pricing of Underwritten Offering Feb 8, 2024 07:00AM
Needham & Company Reiterates Buy Rating, $13 Price Target on Autolus Therapeutics (AUTL) Apr 18, 2022 08:54AM


Mar 29, 2022 07:00AM Autolus Therapeutics to Participate in Conferences During April 2022
Mar 29, 2022 07:00AM Autolus Therapeutics to Participate in Conferences During April 2022
Mar 10, 2022 04:41PM Needham & Company Reiterates Autolus Therapeutics plc (AUTL) at Buy, Views Clinical Profile of obe-cel as Potentially Best-in-Class
May 6, 2021 11:19AM AUTL (AUTL) PT Lowered to $21 at Needham & Company
Apr 1, 2021 04:01PM Autolus Therapeutics to Participate in Investor Conferences Through April
Apr 1, 2021 04:01PM Autolus Therapeutics to Participate in Investor Conferences Through April
Feb 12, 2021 04:01PM Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs
Feb 12, 2021 04:01PM Autolus Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional ADSs
Feb 10, 2021 05:54AM Autolus Therapeutics (AUTL) Prices 14.29M ADS Offering at $7/ADS
Feb 9, 2021 08:42PM Autolus Announces Pricing of Public Offering
Feb 9, 2021 08:42PM Autolus Announces Pricing of Public Offering
Feb 8, 2021 04:19PM Autolus Therapeutics (AUTL) Announces $100 Million Proposed Public Offering in the United States
Feb 8, 2021 04:18PM Autolus Announces Proposed Public Offering in the United States
Feb 8, 2021 04:18PM Autolus Announces Proposed Public Offering in the United States
Mar 5, 2020 07:14AM Companies with NDRs 3/05
Sep 23, 2019 06:38AM Needham & Company Starts AUTL (AUTL) at Buy